Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Drug Toxicity: Dose-Dependent Reactions

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

Animal Mitochondrial Genetics

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

The Electron Transport Chain

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Visualization and Quantitative Analysis of Genotoxin-induced PARP1/PARP2 Activation in Cells using a Fluorescent Fusion Protein-based Reporter.

Journal of visualized experiments : JoVE·2026

Same author

Ubiquitylation of DNA polymerase β via atypical K27 chains signals a DNA damage response.

Nucleic acids research·2026

Same author

Implementing the design cues of dissociation dynamics and transmetalation in gallium(iii) complexes to promote the anti-proliferative activity of ligands targeting intracellular iron(ii) trafficking.

Chemical science·2026

Same author

A Centralized Survey Model for Clinician Engagement in Practice-Based Research Networks (PBRNs).

Journal of the American Board of Family Medicine : JABFM·2026

Same author

Conventional approaches to indicators and metrics undermine urban climate adaptation.

npj urban sustainability·2026

Same author

Replication-associated base excision repair/single-strand break repair regulates PARG inhibitor response via the PRMT1/PRMT5/ATR axis.

NAR cancer·2026

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Simultaneous Mapping and Quantitation of Ribonucleotides in Human Mitochondrial DNA

Simultaneous Mapping and Quantitation of Ribonucleotides in Human Mitochondrial DNA

Published on: November 14, 2017

Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.

Christopher A Koczor¹, William Lewis

¹Emory University, Department of Pathology, Atlanta, GA 30322, USA.

Expert Opinion on Drug Metabolism & Toxicology

|October 9, 2010

Summary

Nucleoside reverse transcriptase inhibitors (NRTIs) are vital for HIV-1 treatment but can cause mitochondrial toxicity by inhibiting human polymerase gamma (pol γ). Future drugs should be more specific to reduce these harmful side effects.

More Related Videos

Cellular Redox Profiling Using High-content Microscopy

Cellular Redox Profiling Using High-content Microscopy

Published on: May 14, 2017

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jun 8, 2026

Simultaneous Mapping and Quantitation of Ribonucleotides in Human Mitochondrial DNA

Simultaneous Mapping and Quantitation of Ribonucleotides in Human Mitochondrial DNA

Published on: November 14, 2017

Cellular Redox Profiling Using High-content Microscopy

Cellular Redox Profiling Using High-content Microscopy

Published on: May 14, 2017

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

Mitochondrial biology
Virology
Pharmacology

Background:

HIV-1 infection remains a global health challenge, transforming from a fatal disease to a chronic condition with nucleoside reverse transcriptase inhibitors (NRTIs).
NRTIs, while effective against HIV-1 replication, can induce toxicity in human tissues by inhibiting mitochondrial polymerase gamma (pol γ).

Purpose of the Study:

To review the mechanisms and clinical manifestations of NRTI-induced mitochondrial toxicity.
To provide a comprehensive understanding of how NRTIs affect mitochondrial genetic homeostasis and energy metabolism.

Main Methods:

This review synthesizes current knowledge on NRTI toxicity, focusing on pol γ inhibition and mitochondrial DNA incorporation.
It details general mechanisms of NRTI toxicity and links specific mitochondrial effects to clinical outcomes.

Main Results:

The review details mitochondrial toxicity stemming from NRTI therapies, including molecular effects on genetic homeostasis and energy metabolism.
It correlates these molecular changes with observable clinical manifestations of NRTI toxicity.

Conclusions:

NRTIs are essential for current HIV-1 treatment, but their mitochondrial toxicity necessitates further research.
Future NRTIs should exhibit greater specificity for HIV-RT and reduced pol γ incorporation, or therapeutic strategies to mitigate mitochondrial damage are required.